Best matches for Dueñas-González A[Author]:

Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy. Schcolnik-Cabrera A et al. Expert Opin Investig Drugs. (2018)

The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug. Juarez M et al. Am J Cancer Res. (2018)

Therapy-related myelodysplastic syndrome. Candelaria M et al. Expert Opin Drug Saf. (2015)

  • History not found.

Supplemental Content

Loading ...
Support Center